Yungjin and Servier on a business alliance.
Published: 2005-10-12 06:56:00
Updated: 2005-10-12 06:56:00
Yungjin and Servier have agreed jointly to market Acertil, an ACE inhibitor anti-hypertension drug, and Diamicron MR, an anti-diabetic drug in Korea starting from Oct. this year after celebrating their business association at Daemyeong condo in Danyang on Oct. 7.
The yearly sales of Diamicron ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
